93 related articles for article (PubMed ID: 23982111)
1. Use and discontinued use of menopausal hormone therapy by healthy women in Norway: the Hordaland Women's Cohort study.
Espen Gjelsvik B; Straand J; Hunskaar S; Dalen I; Rosvold EO
Menopause; 2014 May; 21(5):459-68. PubMed ID: 23982111
[TBL] [Abstract][Full Text] [Related]
2. Symptom prevalence during menopause and factors associated with symptoms and menopausal age. Results from the Norwegian Hordaland Women's Cohort study.
Gjelsvik B; Rosvold EO; Straand J; Dalen I; Hunskaar S
Maturitas; 2011 Dec; 70(4):383-90. PubMed ID: 22033103
[TBL] [Abstract][Full Text] [Related]
3. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
Fournier A; Fritel X; Panjo H; Zins M; Ringa V
Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
[TBL] [Abstract][Full Text] [Related]
4. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
5. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation.
Ringa V; Varnoux N; Piault S; Bréart G
Fertil Steril; 2005 Jun; 83(6):1771-9. PubMed ID: 15950650
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
Heinemann K; Rübig A; Strothmann A; Nahum GG; Heinemann LA
J Womens Health (Larchmt); 2008 Sep; 17(7):1151-66. PubMed ID: 18774896
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormone therapy and migraine headache.
Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
[TBL] [Abstract][Full Text] [Related]
9. Hormones down under: hormone therapy use after the Women's Health Initiative.
Travers C; O'Neill SM; Khoo SK; King R
Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):330-5. PubMed ID: 16866795
[TBL] [Abstract][Full Text] [Related]
10. Changing use of hormone therapy among minority women since the Women's Health Initiative.
Helenius IM; Korenstein D; Halm EA
Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
[TBL] [Abstract][Full Text] [Related]
11. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
13. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
Haskell SG; Bean-Mayberry B; Gordon K
Menopause; 2009; 16(3):494-9. PubMed ID: 19182695
[TBL] [Abstract][Full Text] [Related]
14. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
Parazzini F;
Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
[TBL] [Abstract][Full Text] [Related]
15. [Attitudes to estrogen replacement therapy among Norwegian women].
Hallquist AC; Moen MH; Andrew M; Aursnes I
Tidsskr Nor Laegeforen; 2006 Apr; 126(9):1195-7. PubMed ID: 16670739
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
Woodis CB
J Pharm Pract; 2010 Dec; 23(6):540-7. PubMed ID: 21507860
[TBL] [Abstract][Full Text] [Related]
17. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
18. Women's trust in and use of information sources in the treatment of menopausal symptoms.
Huston SA; Jackowski RM; Kirking DM
Womens Health Issues; 2009; 19(2):144-53. PubMed ID: 19272565
[TBL] [Abstract][Full Text] [Related]
19. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
Schonberg MA; Wee CC
J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
[TBL] [Abstract][Full Text] [Related]
20. Hormone therapy: the European women's perspective.
Strothmann A; Schneider HP
Climacteric; 2003 Dec; 6(4):337-46. PubMed ID: 15006255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]